Epic Sciences company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

epicsciences.com

Executives

9

Board of Directors

1

Epic Sciences Board of Director

1 Board of directors

Epic Sciences has 1 board of directors, including Murali Prahalad.

Name

Firm

Work History

Other Seats

Murali Prahalad

Dr. Prahalad brings over eighteen years of executive and entrepreneurial experience in the life sciences industry. Prior to joining Iridia, he served as President and CEO of Epic Sciences, Inc. (EPIC), a venture backed company that builds predictive, blood-based tests of drug response in cancer. While at Epic, Dr. Prahalad helped advance the company’s functional cell profiling technology platform, develop, launch and obtain Medicare reimbursement for its leading test in metastatic prostate cancer and raise over $128M in venture financing. Prior to Epic, Dr. Prahalad also held various roles at Life Technologies Corporation, a global leader in reagents and instruments for biomedical research. His final role at Life Technologies was VP, Corporate Strategy which culminated in the strategic sale of Life Technologies to ThermoFisher Scientific (NYSE: TMO) in 2013 for $15.5B – the largest non-pharmaceutical acquisition in the biotechnology space. Prior to Life Technologies, Dr. Prahalad was VP of Business Development for Sequenom, Inc., a pioneer in blood-based, pre-natal diagnostics. Dr. Prahalad received his B.Sc. with Honors from the University of Michigan and Doctorate in Biochemistry & Molecular Pharmacology from Harvard University.

Epic Sciences

Name

Murali Prahalad

Firm

Work History

Dr. Prahalad brings over eighteen years of executive and entrepreneurial experience in the life sciences industry. Prior to joining Iridia, he served as President and CEO of Epic Sciences, Inc. (EPIC), a venture backed company that builds predictive, blood-based tests of drug response in cancer. While at Epic, Dr. Prahalad helped advance the company’s functional cell profiling technology platform, develop, launch and obtain Medicare reimbursement for its leading test in metastatic prostate cancer and raise over $128M in venture financing. Prior to Epic, Dr. Prahalad also held various roles at Life Technologies Corporation, a global leader in reagents and instruments for biomedical research. His final role at Life Technologies was VP, Corporate Strategy which culminated in the strategic sale of Life Technologies to ThermoFisher Scientific (NYSE: TMO) in 2013 for $15.5B – the largest non-pharmaceutical acquisition in the biotechnology space. Prior to Life Technologies, Dr. Prahalad was VP of Business Development for Sequenom, Inc., a pioneer in blood-based, pre-natal diagnostics. Dr. Prahalad received his B.Sc. with Honors from the University of Michigan and Doctorate in Biochemistry & Molecular Pharmacology from Harvard University.

Other Seats

Epic Sciences

Epic Sciences Management Team

9 Team Members

Epic Sciences has 9 executives. Epic Sciences's founder is Dena Marrinucci. Epic Sciences's current Chief Medical Officer is Richard Wenstrup M D.

Name

Work History

Title

Status

Dena Marrinucci

Founder

Current

Richard Wenstrup M D

Chief Medical Officer

Current

David Nelson

Founder, Chief Executive Officer, President

Former

Murali K Prahalad

Chief Executive Officer, President

Former

Michael R Rodriguez

Chief Financial Officer

Former

Name

Dena Marrinucci

Richard Wenstrup M D

David Nelson

Murali K Prahalad

Michael R Rodriguez

Work History

Title

Founder

Chief Medical Officer

Founder, Chief Executive Officer, President

Chief Executive Officer, President

Chief Financial Officer

Status

Current

Current

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.